Pedro R. Grandes Moreno
Principal Investigator
Full Professor at UPV/EHU
Contact
Correo electrónico:Pedro.Grandes@ehu.eus
Tel.:(+34) 946 012 875
Faculty of Medicine and Nursery, Department of Neuroscience
Barrio Sarriena, s/n
E-48940 Leioa Spain
About me
Publications
-
The effect of traumatic brain injury on learning and memory: A synaptic focus - Eric Eyolfson, Kirsten R. B. Suesser, Holly Henry, Itziar Bonilla-Del RÃo, Pedro Grandes, Richelle Mychasiuk, Brian R. Christie, 2024
Neuroscientist (Sep, 2024) DOI: 10.1177/10738584241275583 -
Olfactory bulb astrocytes link social transmission of stress to cognitive adaptation in male mice
Nature Communications (Aug, 2024) DOI: 10.1038/s41467-024-51416-4 -
Omega-3 Recovers Cannabinoid 1 Receptor Expression in the Adult Mouse Brain after Adolescent Binge Drinking
International Journal of Molecular Sciences (Dec, 2023) DOI: 10.3390/ijms242417316 -
Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease
Glia (Apr, 2023) DOI: 10.1002/glia.24312 -
The effect of omega-3 fatty acids on alcohol-induced damage
Frontiers in Nutrition (Apr, 2023) -
Target cell-specific plasticity rules of NMDA receptor-mediated synaptic transmission in the hippocampus
Frontiers in Cellular Neuroscience (Apr, 2023) DOI: 10.3389/fncel.2023.1068472 -
Differential Subcellular Distribution and Release Dynamics of Cotransmitted Cholinergic and GABAergic Synaptic Inputs Modify Dopaminergic Neuronal Excitability
Journal of Neuroscience (Nov, 2022) DOI: 10.1523/JNEUROSCI.2514-21.2022 -
Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat
Frontiers in Neuroanatomy (Oct, 2022) DOI: 10.3389/fnana.2022.1004702 -
GLAST versus GFAP as astroglial marker for the subcellular study of cannabinoid CB1 receptors in astrocytes
Histochemistry and Cell Biology (Jul, 2022) DOI: 10.1007/s00418-022-02139-4 -
Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
Frontiers in Pharmacology (Apr, 2022) DOI: 10.3389/fphar.2022.841766